A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
Key Details
- 1Senate Democrats attempted to use the Congressional Review Act to stop the CMS WISeR program but lost 46-50.
- 2WISeR uses AI to automate the approval and denial of traditional Medicare claims in six states.
- 3The pilot involves multiple private vendors: Cohere Health, Genzeon Corporation, Humata Health, Innovaccer, Virtix Health, and Zyter.
- 4Opponents cite risks of care delays and denials for seniors due to AI-driven prior authorizations.
- 5Supporters argue the pilot could reduce waste and fraud in Medicare.
Why It Matters
AI-driven prior authorization has major implications for radiology reimbursement, patient access, and care delays. This marks a pivotal test of AI’s regulatory and economic impact on healthcare workflows, particularly for imaging services.
Source
HealthExec
Related News
•Radiology Business
Radiology Partners Urges FDA for Clarity on Imaging AI Regulations
Radiology Partners and Mosaic Clinical Technologies petition the FDA for clearer regulatory guidelines on imaging AI vision-language models.
•Radiology Business
FDA Solicits Public Input on Regulating Generative AI in Medical Devices
The FDA is seeking public feedback on how to regulate generative AI in medical devices, recognizing both its promise and risks.
•HealthExec
AI's Role in Eliminating Cervical Cancer: A Model for Disease Prevention
Researchers highlight how AI can accelerate the elimination of cervical cancer and set a precedent for combating other diseases.